Breaking News, Collaborations & Alliances

Telix, Eczacıbaşı-Monrol Sign Manufacturing Agreement

Working together for six months on tech transfer of radiopharmaceutical manufacturing methods for TLX250-CDx

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Telix Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or “molecularly-targeted radiation” (MTR) has concluded a master services and distribution agreement with Eczacıbaşı-Monrol.   Under the terms of the agreement, Telix has appointed Eczacıbaşı-Monrol as a radiopharmaceutical production partner and distributor in Turkey/Middle East/North Africa. Eczacıbaşı-Monrol is commercially ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters